Meta Pixel

News and Announcements

Proteomics PromarkerD Development Advances in China

  • Published June 14, 2016 2:06PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

14th June 2016, ASX Announcement

Highlights:

  • PILL and its Chinese partner Newsummit Biopharma have secured funding towards development for an In vitro Diagnostic (IVD) kit for PromarkerD in China.
  • Chinese patent granted for PromarkerD as a predictive and diagnostic test for diabetic kidney disease.
  •  Initial tranche of funding under the PILL-NSB agreement will  support the first stage of PromarkerD IVD kit manufacture.
  • China is a key global market for PILL – WHO estimates 120m Chinese have diabetes and are at risk of kidney disease.

Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce significant advances towards commercialisation of PromarkerD as an In vitrro Diagnostic (IVD) test in China, with the grant of a key patent and funds secured to initiate kit manufacture.

To view the full announcement, please click on the button below.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now